TRESSLER

v.

TRESSLER ET AL.

Citator

Cited By

• Inwood Labs., Inc. v. Ives Labs., Inc., 456 U.S. 844 (U.S. 1982)
  …oners were not in a position directly to suggest improper drug substitutions. Cf. William R. Warner & Co. v. Eli Lilly & Co., 265 U. S. 526, 530-531 (1924); Smith, Kline & French Laboratories v. Clark & Clark, 157 F. 2d 725, 731 (CA3), cert. denied, 329 U. S. 796 (1946). Therefore, the court concluded, improper suggestions, if any, must have come from catalogs and promotional materials. The court determined, however, that those materials could not “fairly be read” to suggest trademark infringement. 488 F. Su…
• SK&F v. Premo Pharm. Labs., Inc., 625 F.2d 1055 (3d Cir. 1980)
  …ement); Press Pub. Co. v. Atlantic County Advert., Inc., 108 N.J.Super. 75, 81, 260 A. 2d 6, 9 (Ch.Div. 1969), aff’d, 59 N.J. 356, 283 A. 2d 102 (1971); see Smith, Kline & French Labs. v. Clark & Clark, 157 F. 2d 725, 730-31 (3d Cir.), cert. denied, 329 U.S. 796, 67 S.Ct. 482, 91 L.Ed. 681 (1946); Columbia Broadcasting Sys., Inc. v. Melody Recordings, Inc., 134 N.J.Super. 368, 341 A. 2d 348, 352 (App.Div. 1975). The New Jersey cases define these two torts in roughly the same manner as did the First Restatem…
• Ives Labs., Inc. v. Darby Drug Co., Inc., 601 F.2d 631 (2d Cir. 1979)
  …inent decisions of courts of appeals in the interval between Kellogg and Sears-Comp-co — one before and the others after the effective date of the Lanham Act. Smith, Kline & French Laboratories v. Clark & Clark, 157 F. 2d 725 (3 Cir.), cert. denied, 329 U.S. 796, 67 S.Ct. 482, 91 L.Ed. 681 (1946), involved both patent and unfair competition claims relating to amphetamine sulphate tablets, a prescription drug. The court found that the shape, color and scoring of the tablets were functional. Partially reversi…